Журнал Cancer World опубликовал статью "Masterpice", посвященную профессору Давиду Георгиевичу Зарид
The Moscow smokebuster
There are smokers in Russia alive today thanks to David Zaridze and the lead he took in halving tar levels 20 years ago. He has a long history in cancer prevention, but believes the biggest gains may lie in early detection. Will the country that discovered the first liver cancer marker soon give the world the first proteomic marker for lung cancer?
Lung cancer deaths have been in decline in Russia since the mid 1990s, which is perhaps surprising given that 35 million Russians smoke and show few signs of giving up the habit (70% of young men and 25–30% of young women are current smokers).
Mortality from all cancers in Russia is still higher than in the US and other Western countries. Lung cancer deaths in Russian men are a third higher than in Western Europe. Yet after rising steadily between 1965 and the early 1990s, the age-standardised death rates from lung cancer levelled out and then began to fall. David Zaridze, Deputy Director of the N N Blokhin Cancer Research Centre in Moscow and Director of the Institute of Carcinogenesis, traces the turning point to the first meeting on smoking prevention in what was then the Soviet Union, in 1985.
Zaridze organised the meeting in conjunction with the International Agency for Research on Cancer (IARC) and the renowned Oxford University epidemiologists Richard Doll and Richard Peto. The meeting was attended by influential Russian doctors and senior officials from the Ministry of Public Health and other agencies...